Please complete the CAPTCHA to continue
@accessbio.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Joy Cavagnaro is listed as President at Access BIO at Access BIO, based in Boyce, Virginia, United States. AeroLeads shows a work email signal at accessbio.com and a matched LinkedIn profile for Joy Cavagnaro.
Joy Cavagnaro previously worked as President at Access Bio and Vice President, Regulatory Affairs and Integrated Compliance at Human Genome Sciences. Joy Cavagnaro holds Ph.D., Biochemistry from University Of North Carolina At Chapel Hill.
This section adds company-level context without repeating Joy Cavagnaro's masked contact details.
AeroLeads found 1 current-domain work email signal for Joy Cavagnaro. Compare company email patterns before reaching out.
Joy A. Cavagnaro, PhD, DABT, ATS, RAC, FRAPS is an internationally recognized translational scientist with 40 years experience spanning academia, the CRO and Biotechnology Industries and FDA. Recognized for pioneering the “case-by-case approach” for preclinical safety evaluations of biopharmaceuticals. Passionate about good science, novel technologies, telling the story and Special Olympics.
Listed skills include Ind, Toxicology, Biopharmaceuticals, Translational Medicine, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Consultancy specializing in science-based regulatory strategies and development services to facilitate translation of biomedical research, emerging technologies and product development. Product classes include vaccines, cellular [including stem cells] and gene therapies, animal-based and plant-based bio-therapeutics, biotechnology-derived and tissue.
Rockville, MD, US
Established the Regulatory Affairs Department, which included regulatory affairs and clinical data management data programming functions and assisted in identifying and developing new pre-clinical opportunities.Served as company spokesperson with the FDA and foreign agencies in all aspects of the regulatory process.Provided regulatory oversight for the.
Silver Spring, MD, US
Responsible for inter-center and international policy guidance for the preclinical development and safety assessment of biological products. Spokesperson for CBER at local, and national and international meetings related to pharm/tox aspects of biologic product review. From 1990-1997 served as FDA safety topic lead for the International Conference on.
Silver Spring, MD, US
Served as ex officio center representative to the National Center for Toxicological Research Scientific Advisory Board.(1993-1997) Assisted in planning and developing policy and programs that set standards for traditional biologicals and biotechnology products. Served as a member on the Review Management Coordinating Committee. Chaired working group to.
Silver Spring, MD, US
Developed pharmacology/toxicology policy and implemented guiding principles for CBER product application review and surveillance. Ensured interdivisional and interoffice consistency regarding design and analysis of pre-clinical studies. Co-chaired the Intercenter Committee on the Use of Transgenic Animals to Produce Therapeutics for Human Use. From.
Silver Spring, MD, US
Managed OBRR interface with intramural and extramural pharmacology/toxicology programs and issues. Provided leadership in addressing pharmacology/toxicology issues to the five research division staffs of OBR as well as other offices within CBER. Served as toxicology reviewer on hundreds of INDs and six product license application (PLA) committees. FDA.
Princeton, New Jersey, US
Principal study director for pharmaceutical products derived from biotechnology. Planned, executed, and carried out the program for the safety evaluation of biotechnology-derived products in cooperation with appropriate scientific specialists at the various Hazleton laboratories worldwide. Served as the primary contact for developing pre-clinical.
Princeton, New Jersey, US
As principal investigator for all genetic toxicology studies, directed programs to evaluate chemicals, particulate, drugs, and biologics in a series of assays designed to determine potential, mutagenic or carcinogenic risks. Managed all costs and revenues for the laboratories under supervision. Interfaced with the FDA, EPA an other regulatory agencies to.
Princeton, New Jersey, US
Quick answers generated from the profile data available on this page.
Joy Cavagnaro works for Access BIO.
Joy Cavagnaro is listed as President at Access BIO at Access BIO.
AeroLeads has found 1 work email signal at @accessbio.com for Joy Cavagnaro at Access BIO.
Joy Cavagnaro is based in Boyce, Virginia, United States while working with Access BIO.
Joy Cavagnaro has worked for Access Bio, Human Genome Sciences, Fda, and Covance.
You can use AeroLeads to view verified contact signals for Joy Cavagnaro at Access BIO, including work email, phone, and LinkedIn data when available.
Joy Cavagnaro holds Ph.D., Biochemistry from University Of North Carolina At Chapel Hill.
Joy Cavagnaro is listed with skills including Ind, Toxicology, Biopharmaceuticals, Translational Medicine, Regulatory Affairs, Biotechnology, Vaccines, and Glp.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts